Patents by Inventor Morten Lind Jensen

Morten Lind Jensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BASAL TITRATION WITH ADAPTIVE TARGET GLUCOSE LEVEL
    Publication number: 20220184310
    Abstract: Systems and methods are provided for adjusting long acting insulin medicament dosages for a subject. A plurality of timestamped glucose measurements of the subject is obtained. A titration glucose level (246) is computed as a measure of central tendency (244, 268, 274) of a titration subset of small glucose measurements (240, 269, 273) identified within the timestamped glucose measurements, wherein the measure of central tendency represents a measure of small glucose measurements for the primary time window. A long acting insulin medicament dosage (216) is adjusted or maintained based upon the obtained titration glucose level (246).
    Type: Application
    Filed: March 4, 2022
    Publication date: June 16, 2022
    Inventors: Tinna Bjoerk Aradottir, Henrik Bengtsson, Morten Lind Jensen, Pete Brockmeier
  • Basal titration with adaptive target glucose level
    Patent number: 11298461
    Abstract: Systems and methods are provided for adjusting long acting insulin medicament dosages for a subject. A plurality of timestamped glucose measurements of the subject is obtained. A titration glucose level (246) is computed as a measure of central tendency (244, 268, 274) of a titration subset of small glucose measurements (240, 269, 273) identified within the timestamped glucose measurements, wherein the measure of central tendency represents a measure of small glucose measurements for the primary time window. A long acting insulin medicament dosage (216) is adjusted or maintained based upon the obtained titration glucose level (246).
    Type: Grant
    Filed: June 8, 2018
    Date of Patent: April 12, 2022
    Assignee: Novo Nordisk A/S
    Inventors: Tinna Bjoerk Aradottir, Henrik Bengtsson, Morten Lind Jensen, Pete Brockmeier
  • BASAL TITRATION WITH ADAPTIVE TARGET GLUCOSE LEVEL
    Publication number: 20210146046
    Abstract: Systems and methods are provided for adjusting long acting insulin medicament dosages for a subject. A plurality of timestamped glucose measurements of the subject is obtained. A titration glucose level (246) is computed as a measure of central tendency (244, 268, 274) of a titration subset of small glucose measurements (240, 269, 273) identified within the timestamped glucose measurements, wherein the measure of central tendency represents a measure of small glucose measurements for the primary time window. A long acting insulin medicament dosage (216) is adjusted or maintained based upon the obtained titration glucose level (246).
    Type: Application
    Filed: June 8, 2018
    Publication date: May 20, 2021
    Inventors: Tinna Bjoerk Aradottir, Henrik Bengtsson, Morten Lind Jensen, Pete Brockmeier